Výsledky vyhľadávania - "Pyridines adverse effects"
-
1
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: Journal of Neurosurgery. :1-12
Predmety: Male, Vasospasm, Intracranial/diagnostic imaging, Pyridines, Tetrazoles, cerebral ischemia, Brain Ischemia, Dioxanes, 0302 clinical medicine, Vasospasm, Intracranial, Pyridines/administration & dosage, Prospective Studies, Human health sciences, clazosentan, Vasospasm, Intracranial/prevention & control, Pyridines/therapeutic use, Sulfonamides, Subarachnoid Hemorrhage/diagnostic imaging, Anesthesia & intensive care, Middle Aged, Brain Ischemia/etiology, 3. Good health, Dioxanes/therapeutic use, Treatment Outcome, Neurology, Tetrazoles/therapeutic use, endothelin-1, Vasospasm, Intracranial/etiology, Dioxanes/adverse effects, Female, Tetrazoles/adverse effects, Adult, Anesthésie & soins intensifs, subarachnoid hemorrhage, vascular disorders, Sciences de la santé humaine, 03 medical and health sciences, Double-Blind Method, Neurologie, Humans, Pyrimidines/administration & dosage, Pyridines/adverse effects, aneurysm, cerebral vasospasm, Aged, Sulfonamides/administration & dosage, Pyrimidines/adverse effects, Pyrimidines/therapeutic use, Sulfonamides/adverse effects, Sulfonamides/therapeutic use, Subarachnoid Hemorrhage, Vasospasm, Intracranial/drug therapy, Pyrimidines, Subarachnoid Hemorrhage/complications, Surgery, Neurology (clinical), Brain Ischemia/prevention & control
Popis súboru: application/pdf
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39126720
-
2
Autori: a ďalší
Zdroj: Vasc Health Risk Manag
Kwon, S, Lee, S-R, Choi, E-K, Lee, K-Y, Choi, J, Ahn, H-J, Oh, S & Lip, G Y H 2024, 'Perioperative Management in Patients with Atrial Fibrillation Treated with Non-Vitamin K Antagonist Oral Anticoagulants Undergoing Minor Bleeding Risk Procedure: Rationale and Protocol for the PERIXa Study', Vascular Health and Risk Management, vol. 20, pp. 231-244. https://doi.org/10.2147/VHRM.S455530Predmety: Time Factors, perioperative care, Pyridones, Pyridines, Administration, Oral, Hemorrhage, direct factor Xa inhibitor, Risk Assessment, Perioperative Care, Drug Administration Schedule, Perioperative Care/methods, Study Protocol, 03 medical and health sciences, 0302 clinical medicine, Rivaroxaban, Pyridones/adverse effects, oral anticoagulant, Risk Factors, Hemorrhage/chemically induced, Pyrazoles/adverse effects, Atrial Fibrillation, Atrial Fibrillation/diagnosis, Humans, Multicenter Studies as Topic, atrial fibrillation, Prospective Studies, Registries, Factor Xa Inhibitors/adverse effects, Pyridines/adverse effects, Rivaroxaban/adverse effects, bleeding, 3. Good health, Thiazoles, Treatment Outcome, Research Design, Pyrazoles, Factor Xa Inhibitors
Popis súboru: application/pdf
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38774425
http://www.scopus.com/inward/record.url?scp=85194026459&partnerID=8YFLogxK
https://vbn.aau.dk/da/publications/c745a5c9-6a22-436d-8bd0-4bf31d82a9d1
https://vbn.aau.dk/ws/files/717193986/Kwon_et_al._2024_._Perioperative_Management_in_Patients_with_Atrial_Fibrillation_Treated_with_Non-Vitamin_K_Antagonist_Oral_Anticoagulants_Undergoing_Minor_Bleeding_Risk_Procedure_-_Rationale_and_Protocol_for_the_PERIXa_Study.pdf
https://doi.org/10.2147/VHRM.S455530 -
3
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: Clinical colorectal cancer, vol. 24, no. 1, pp. 82-88.e1
Predmety: Humans, Capecitabine/administration & dosage, Capecitabine/adverse effects, Male, Pyridines/administration & dosage, Pyridines/adverse effects, Female, Middle Aged, Rectal Neoplasms/therapy, Rectal Neoplasms/pathology, Rectal Neoplasms/mortality, Phenylurea Compounds/administration & dosage, Phenylurea Compounds/adverse effects, Aged, Neoadjuvant Therapy/methods, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Adult, Chemoradiotherapy/methods, Neoadjuvant chemoradiation, Pathological response, Phase I, Toxicity, Tyrosine kinase inhibitors (TKI)
Popis súboru: application/pdf
Relation: info:eu-repo/semantics/altIdentifier/pmid/39537446; info:eu-repo/semantics/altIdentifier/eissn/1938-0674; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_A4FE1C2C87680; https://serval.unil.ch/notice/serval:BIB_A4FE1C2C8768; https://serval.unil.ch/resource/serval:BIB_A4FE1C2C8768.P001/REF.pdf
-
4
Autori: a ďalší
Zdroj: BMC Cancer
Bmc Cancer
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Instituto de Investigación Sanitaria La Fe (IIS La Fe)
BMC Cancer, Vol 24, Iss 1, Pp 1-9 (2024)Predmety: Male, Adult, Aged, 80 and over, ddc:610, Skin Neoplasms, Pyridines, Research, Biphenyl Compounds, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Antineoplastic Agents, Middle Aged, Dysgeusia, Sonidegib, Hedgehog pathway inhibitors, Young Adult, 03 medical and health sciences, Treatment Outcome, 0302 clinical medicine, Carcinoma, Basal Cell, Basal cell carcinoma, Humans, Female, RC254-282, Antineoplastic Agents/adverse effects [MeSH], Aged, 80 and over [MeSH], Carcinoma, Basal Cell/drug therapy [MeSH], Aged [MeSH], Pyridines/adverse effects [MeSH], Antineoplastic Agents/administration, Skin Neoplasms/drug therapy [MeSH], Biphenyl Compounds/therapeutic use [MeSH], Male [MeSH], Dysgeusia/epidemiology [MeSH], Biphenyl Compounds/adverse effects [MeSH], Dysgeusia/chemically induced [MeSH], Female [MeSH], Pyridines/therapeutic use [MeSH], Adult [MeSH], Humans [MeSH], Pyridines/administration, Treatment Outcome [MeSH], Middle Aged [MeSH], Carcinoma, Basal Cell/pathology [MeSH], Skin Neoplasms/pathology [MeSH], Young Adult [MeSH], Antineoplastic Agents/therapeutic use [MeSH], Aged
Popis súboru: application/pdf
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39538176
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=21993
https://doaj.org/article/f6af041d3b7c44cf9ec6506be11d5de8
https://hss-opus.ub.ruhr-uni-bochum.de/opus4/frontdoor/index/index/docId/11827
https://hss-opus.ub.ruhr-uni-bochum.de/opus4/files/11827/GutzmerRalf14112024.pdf
https://nbn-resolving.org/urn:nbn:de:hbz:294-118274
https://repository.publisso.de/resource/frl:6493652 -
5
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
New England Journal of Medicine, vol 389, iss 7Predmety: Biomedical and clinical sciences, Glioma / genetics, Pyridines, Clinical Sciences, Oncology and Carcinogenesis, Clinical Trials and Supportive Activities, Antineoplastic Agents, Medical and Health Sciences, Neoplasm Recurrence, Local / drug therapy, Pyridines / adverse effects, Rare Diseases, Double-Blind Method, Clinical Research, General & Internal Medicine, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, Enzyme Inhibitors / therapeutic use, Antineoplastic Combined Chemotherapy Protocols, Humans, Enzyme Inhibitors, Cancer, Isocitrate Dehydrogenase / genetics, Biomedical and Clinical Sciences, Neurosciences, INDIGO Trial Investigators, Health sciences, Glioma, Antineoplastic Agents / therapeutic use, Isocitrate Dehydrogenase, 3. Good health, Brain Disorders, Brain Cancer, Neoplasm Recurrence, Local, 6.1 Pharmaceuticals, Glioma / drug therapy, Disease Progression, Neoplasm Recurrence, Local
Popis súboru: application/pdf
-
6
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: Journal of Neurosurgery, 142 (1), 98 - 109 (2025-01-01)
Predmety: aneurysm, cerebral ischemia, cerebral vasospasm, clazosentan, endothelin-1, subarachnoid hemorrhage, vascular disorders, Pyridines, Dioxanes, Pyrimidines, Sulfonamides, Tetrazoles, Humans, Male, Middle Aged, Female, Double-Blind Method, Aged, Prospective Studies, Treatment Outcome, Adult, Vasospasm, Intracranial/etiology, Vasospasm, Intracranial/prevention & control, Vasospasm, Intracranial/drug therapy, Vasospasm, Intracranial/diagnostic imaging, Subarachnoid Hemorrhage/complications, Subarachnoid Hemorrhage/diagnostic imaging, Pyridines/therapeutic use, Pyridines/adverse effects, Pyridines/administration & dosage, Dioxanes/therapeutic use, Dioxanes/adverse effects, Pyrimidines/therapeutic use, Pyrimidines/adverse effects, Pyrimidines/administration & dosage, Brain Ischemia/prevention & control, Brain Ischemia/etiology, Sulfonamides/therapeutic use, Sulfonamides/adverse effects, Sulfonamides/administration & dosage, Tetrazoles/therapeutic use, Tetrazoles/adverse effects, Brain Ischemia, Vasospasm, Intracranial, Surgery, Neurology (clinical), Human health sciences, Neurology, Anesthesia & intensive care, Sciences de la santé humaine, Neurologie, Anesthésie & soins intensifs
Relation: https://thejns.org/view/journals/j-neurosurg/aop/article-10.3171-2024.4.JNS232191/article-10.3171-2024.4.JNS232191.xml; urn:issn:0022-3085; urn:issn:1933-0693
Prístupová URL adresa: https://orbi.uliege.be/handle/2268/328394
-
7
Autori:
Zdroj: Strahlenther Onkol
Predmety: Glioma/drug therapy [MeSH], Brain Neoplasms/radiotherapy [MeSH], Pyridines/therapeutic use [MeSH], Diamines/therapeutic use [MeSH], Humans [MeSH], Pyridines/adverse effects [MeSH], Literatur Kommentiert, Brain Neoplasms/drug therapy [MeSH], Diamines/adverse effects [MeSH]
Prístupová URL adresa: https://repository.publisso.de/resource/frl:6516110
-
8
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: Invest New Drugs
Investigational New Drugs, vol 40, iss 5Predmety: 0301 basic medicine, Lung Neoplasms, Non-Small-Cell Lung / drug therapy, Pyridines, Lung Neoplasms / drug therapy, 03 medical and health sciences, Rare Diseases, Objective response rate, 0302 clinical medicine, Anilides* / adverse effects, Clinical Research, Carcinoma, Non-Small-Cell Lung, Neoplasms, Tumor Microenvironment, Humans, Pyridines* / adverse effects, Pharmacokinetics, Anilides, Oncology & Carcinogenesis, Non-Small-Cell Lung, Lung, 6.2 Cellular and gene therapies, Cancer, Research, Lung Cancer, Carcinoma, Sitravatinib, Evaluation of treatments and therapeutic interventions, Neoplasms* / pathology, Pharmacology and Pharmaceutical Sciences, 3. Good health, 6.1 Pharmaceuticals, Adverse events, Neoplasms* / drug therapy, Advanced solid tumors
Popis súboru: application/pdf
-
9
Autori: a ďalší
Zdroj: BMC Pulm Med
BMC Pulmonary Medicine, Vol 24, Iss 1, Pp 1-5 (2024)Predmety: Adult, Male, 0301 basic medicine, Indoles, Pyrrolidines, Adolescent, Cystic Fibrosis, Pyridines, Medizin, Liver dysfunction, Case Report, Gilbert's syndrome, Quinolones, Aminophenols, Cystic fibrosis, Diseases of the respiratory system, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Humans, Elexacaftor/tezacaftor/ivacaftor, Pyrroles, Benzodioxoles, Glucuronosyltransferase, Hyperbilirubinemia, RC705-779, Cystic Fibrosis/drug therapy [MeSH], Hyperbilirubinemia/chemically induced [MeSH], Pyrazoles/adverse effects [MeSH], Benzodioxoles/adverse effects [MeSH], Drug Combinations [MeSH], Pyridines/adverse effects [MeSH], Drug intolerance, Pyrazoles/therapeutic use [MeSH], Pyrroles/adverse effects [MeSH], Benzodioxoles/therapeutic use [MeSH], Aminophenols/therapeutic use [MeSH], Male [MeSH], Indoles/adverse effects [MeSH], Adolescent [MeSH], Female [MeSH], Quinolones/adverse effects [MeSH], Pyridines/therapeutic use [MeSH], Adult [MeSH], Cystic Fibrosis/complications [MeSH], Humans [MeSH], Gilbert Disease/drug therapy [MeSH], Pyrrolidines [MeSH], Quinolines [MeSH], Young Adult [MeSH], Glucuronosyltransferase/genetics [MeSH], Gilbert Disease/genetics [MeSH], Aminophenols/adverse effects [MeSH], Quinolones/therapeutic use [MeSH], 3. Good health, Drug Combinations, Quinolines, Pyrazoles, Female, Gilbert Disease
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38956524
https://doaj.org/article/e7f10fbf6acf4c76954ab790ee4ad480
https://repository.publisso.de/resource/frl:6524398
https://www.ncbi.nlm.nih.gov/pubmed/38956524
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85197650229
https://doi.org/10.1186/s12890-024-03114-6 -
10
Autori: a ďalší
Zdroj: European Journal of Cancer, 161, pp. 128-137
Predmety: Male, Receptor Protein-Tyrosine Kinases/pharmacology, Pyridines, Radboudumc 17: Women's cancers RIHS: Radboud Institute for Health Sciences, Radboudumc 15: Urological cancers RIHS: Radboud Institute for Health Sciences, 03 medical and health sciences, Radboudumc 16: Vascular damage RIHS: Radboud Institute for Health Sciences, 0302 clinical medicine, Humans, Anilides, Neoplasm Metastasis, Medical Oncology - Radboud University Medical Center, Anilides/adverse effects, Pyridines/adverse effects, Aged, Pathology - Radboud University Medical Center, Receptor Protein-Tyrosine Kinases, Radboudumc 9: Rare cancers RIHS: Radboud Institute for Health Sciences, Middle Aged, Salivary Gland Neoplasms, 3. Good health, Salivary Gland Neoplasms/drug therapy, Neoplasm Recurrence, Local, Radiation Oncology - Radboud University Medical Center, Female, Neoplasm Recurrence, Local, Health Evidence - Radboud University Medical Center
-
11
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: New England Journal of Medicine. 385:815-825
Predmety: Adult, Male, Indoles, adolescent, adult, aminophenols, benzodioxoles, child, chloride channel agonists, chlorides, cystic fibrosis, cystic fibrosis transmembrane conductance regulator, double-blind method, drug combinations, female, genotype, humans, indoles, male, pyrazoles, pyridines, quinolines, sweat, Adolescent, Cystic Fibrosis, Genotype, Pyridines, Chloride Channel Agonists/adverse effects, Medizin, Cystic Fibrosis Transmembrane Conductance Regulator, Aminophenols/adverse effects, Aminophenols, Sweat/chemistry, 03 medical and health sciences, [SDV.MHEP.PED] Life Sciences [q-bio]/Human health and pathology/Pediatrics, 0302 clinical medicine, Chlorides, Double-Blind Method, Pyrazoles/adverse effects, Humans, Benzodioxoles, Child, Chloride Channel Agonists, Sweat, Pyridines/adverse effects, Quinolines/adverse effects, General Medicine, 3. Good health, Drug Combinations, [SDV.SP.PHARMA] Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, Chlorides/analysis, Quinolines, Cystic Fibrosis Transmembrane Conductance Regulator/genetics, Indoles/adverse effects, [SDV.MHEP.PSR] Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract, Pyrazoles, Female, Cystic Fibrosis/drug therapy, Benzodioxoles/adverse effects
Popis súboru: application/pdf
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/34437784
https://dspace.library.uu.nl/handle/1874/443575
https://biblio.vub.ac.be/vubir/triple-therapy-for-cystic-fibrosis-phe508delgating-and-residual-function-genotypes(d6c86ecb-1924-4fc2-b77d-25ba4a1064a7).html -
12
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: The Lancet Oncology. 22:959-969
Predmety: Male, Pyrazoles / therapeutic use, Lung Neoplasms, Time Factors, Gene Fusion, Pyridines, Lung Neoplasms / pathology, Lung Neoplasms / drug therapy, Antineoplastic Agents, Antineoplastic Agents / therapeutic use, Pyridines / adverse effects, Protein Kinase Inhibitors / therapeutic use, 03 medical and health sciences, Proto-Oncogene Proteins c-ret / genetics, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Pyrimidines / adverse effects, Pyrimidines / therapeutic use, Biomarkers, Tumor, Humans, Tumor / genetics, Pyridines / therapeutic use, Non-Small-Cell Lung / genetics, Protein Kinase Inhibitors, Non-Small-Cell Lung / drug therapy, Protein Kinase Inhibitors / adverse effects, Aged, Lung Neoplasms / genetics, Pyrazoles / adverse effects, Antineoplastic Agents / adverse effects, Carcinoma, Proto-Oncogene Proteins c-ret, Middle Aged, 3. Good health, Proto-Oncogene Proteins c-ret / antagonists & inhibitors, Pyrimidines, Treatment Outcome, Pyrazoles, Female, Non-Small-Cell Lung / pathology, Biomarkers
Popis súboru: application/pdf
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/34118197
https://digitalcommons.psjhealth.org/publications/4949/
https://mayoclinic.pure.elsevier.com/en/publications/pralsetinib-for-ret-fusion-positive-non-small-cell-lung-cancer-ar
https://www.ncbi.nlm.nih.gov/pubmed/34118197
https://europepmc.org/article/MED/34118197
https://pubmed.ncbi.nlm.nih.gov/34118197/
https://ir.ymlib.yonsei.ac.kr/handle/22282913/184725
https://hdl.handle.net/2434/849960
https://doi.org/10.1016/S1470-2045(21)00247-3 -
13
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: New England Journal of Medicine, vol 383, iss 9
Predmety: Male, Biomedical and clinical sciences, Lung Neoplasms, Pyridines, Medical and Health Sciences, Proto-Oncogene Proteins c-ret / genetics, Carcinoma, Non-Small-Cell Lung, 80 and over, Non-Small-Cell Lung, Lung, Cancer, Aged, 80 and over, Lung Cancer, Pyrazoles / administration & dosage, Middle Aged, Progression-Free Survival, Intention to Treat Analysis, 3. Good health, Pyridines / administration & dosage, Transaminases / blood, Treatment Outcome, Hypertension, Female, Adult, Clinical Sciences, Oncology and Carcinogenesis, Clinical Trials and Supportive Activities, Lung Neoplasms / drug therapy, Pyridines / adverse effects, Young Adult, Hypertension / chemically induced, Clinical Research, General & Internal Medicine, Humans, Protein Kinase Inhibitors, Non-Small-Cell Lung / drug therapy, Transaminases, Protein Kinase Inhibitors / adverse effects, Aged, Pyrazoles / adverse effects, Biomedical and Clinical Sciences, Carcinoma, Proto-Oncogene Proteins c-ret, Health sciences, Protein Kinase Inhibitors / administration & dosage, Proto-Oncogene Proteins c-ret / antagonists & inhibitors, Mutation, Pyrazoles, Proto-Oncogene Proteins c-ret / analysis
Popis súboru: application/pdf
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/32846060
https://mdanderson.elsevierpure.com/en/publications/efficacy-of-selpercatinib-in-ret-fusion-positive-non-small-cell-l
https://www.nejm.org/doi/full/10.1056/NEJMoa2005653
https://snucm.elsevierpure.com/en/publications/efficacy-of-selpercatinib-in-ret-fusion-positive-non-small-cell-l
http://pubmed.ncbi.nlm.nih.gov/32846060/
https://pubmed.ncbi.nlm.nih.gov/32846060/
https://moh-it.pure.elsevier.com/en/publications/efficacy-of-selpercatinib-in-ret-fusion-positive-non-small-cell-l
https://escholarship.org/uc/item/51q687dk
https://escholarship.org/content/qt51q687dk/qt51q687dk.pdf -
14
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: Investigational New Drugs. 39:260-268
Predmety: Male, 0301 basic medicine, Hepatocellular carcinoma, Pyridines, Effectiveness, Kaplan-Meier Estimate, Liver Neoplasms / mortality, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, 80 and over, Pyridines / therapeutic use, Sorafenib / adverse effects, Aged, 80 and over, Liver Neoplasms / drug therapy, Antineoplastic Agents / administration & dosage, Phenylurea Compounds / therapeutic use, Liver Neoplasms, Age Factors, Real-world study, Middle Aged, Phenylurea Compounds / adverse effects, Progression-Free Survival, 3. Good health, Hepatocellular / drug therapy, Phenylurea Compounds / administration & dosage, Female, Safety, Adult, Carcinoma, Hepatocellular, Liver Neoplasms / pathology, Antineoplastic Agents, Antineoplastic Agents / therapeutic use, Pyridines / adverse effects, 03 medical and health sciences, Sex Factors, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, Republic of Korea, Humans, Aged, Retrospective Studies, Phenylurea Compounds, Antineoplastic Agents / adverse effects, Carcinoma, Patient Acuity, Sorafenib / administration & dosage, Hepatocellular / mortality, Hepatocellular / pathology, Sorafenib / therapeutic use, Pyridines / administration & dosage
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/32749658
https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/33931
https://www.ncbi.nlm.nih.gov/pubmed/32749658
https://pubmed.ncbi.nlm.nih.gov/32749658/
https://link.springer.com/article/10.1007/s10637-020-00977-4
https://koreauniv.pure.elsevier.com/en/publications/real-world-systemic-sequential-therapy-with-sorafenib-and-regoraf -
15
Autori: Jörg Trojan
Zdroj: Drugs
Predmety: 0301 basic medicine, ddc:610, Clinical Trials as Topic, Carcinoma, Hepatocellular, Pyridines, Liver Neoplasms, Antineoplastic Agents, Review Article, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, Humans, Anilides/therapeutic use [MeSH], Pharmacology/Toxicology, Antineoplastic Agents/adverse effects [MeSH], Pyridines/therapeutic use [MeSH], Humans [MeSH], Pyridines/adverse effects [MeSH], Carcinoma, Hepatocellular/drug therapy [MeSH], Anilides/adverse effects [MeSH], Clinical Trials as Topic [MeSH], Antineoplastic Agents/therapeutic use [MeSH], Internal Medicine, Liver Neoplasms/drug therapy [MeSH], Pharmacotherapy, Anilides
Popis súboru: application/pdf
Prístupová URL adresa: https://link.springer.com/content/pdf/10.1007/s40265-020-01361-5.pdf
https://pubmed.ncbi.nlm.nih.gov/32671719
https://pubmed.ncbi.nlm.nih.gov/32671719/
https://link.springer.com/content/pdf/10.1007/s40265-020-01361-5.pdf
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395054/
https://www.ncbi.nlm.nih.gov/pubmed/32671719
https://link.springer.com/article/10.1007/s40265-020-01361-5
https://repository.publisso.de/resource/frl:6465121 -
16
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: International Journal of Cardiology. 408:132118
Predmety: Male, Time Factors, Pyridines, Hemorrhage, Atrial fibrillation, Edoxaban, Non-vitamin K antagonist oral anticoagulant, Routine care, Stroke prevention, Europe/epidemiology, Hemorrhage/chemically induced, Atrial Fibrillation, 80 and over, Humans, Prospective Studies, Factor Xa Inhibitors/adverse effects, Pyridines/adverse effects, Stroke/prevention & control, Aged, Aged, 80 and over, 2. Zero hunger, Atrial Fibrillation/drug therapy, 3. Good health, Europe, Stroke, Thiazoles/adverse effects, Thiazoles, Treatment Outcome, Female, aged, 80 and over, Factor Xa Inhibitors, Follow-Up Studies
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38697397
https://pure.amsterdamumc.nl/en/publications/51cb02ae-75f8-496f-858e-42f9068a408e
https://doi.org/10.1016/j.ijcard.2024.132118
https://biblio.vub.ac.be/vubir/(b5274029-b72d-4f39-9de8-f84bfd63dafc).html
https://doi.org/10.1016/j.ijcard.2024.132118
https://hdl.handle.net/20.500.14017/b5274029-b72d-4f39-9de8-f84bfd63dafc -
17
Autori: a ďalší
Predmety: Adolescent, Adult, Area Under Curve, Blood Pressure/drug effects, Body Weight, Cross-Over Studies, Dose-Response Relationship, Drug, Electrolytes/blood, Electrolytes/urine, Glomerular Filtration Rate/drug effects, Heart Rate/drug effects, Humans, Kidney/blood supply, Kidney/drug effects, Male, Pyridines/administration & dosage, Pyridines/adverse effects, Pyrimidines/administration & dosage, Pyrimidines/adverse effects, Receptors, Endothelin/antagonists & inhibitors, Regional Blood Flow/drug effects, Sodium/metabolism, Young Adult
Relation: Clinical Pharmacology and Therapeutics; 1532-6535[electronic]; https://iris.unil.ch/handle/iris/36624; serval:BIB_11E8FF45CFE0; 000266290000018
-
18
Autori: a ďalší
Prispievatelia: a ďalší
Predmety: Adenine/adverse effects, Adenine/analogs & derivatives, Adult, Benzoxazines/adverse effects, Drug Therapy, Combination/adverse effects, Combination/methods, Female, Glomerular Filtration Rate/drug effects, HIV Infections/drug therapy, HIV Protease Inhibitors/administration & dosage, HIV Protease Inhibitors/adverse effects, Humans, Kidney/drug effects, Kidney/physiopathology, Lopinavir/adverse effects, Male, Middle Aged, Oligopeptides/adverse effects, Organophosphonates/adverse effects, Pyridines/adverse effects, Reverse Transcriptase Inhibitors/administration & dosage, Reverse Transcriptase Inhibitors/adverse effects, Ritonavir/adverse effects, Treatment Outcome
Relation: AIDS; https://iris.unil.ch/handle/iris/242272; serval:BIB_E49D4C7F0E9D; 000301333000006
-
19
Autori: a ďalší
Prispievatelia: a ďalší
Predmety: Adult, Aged, 80 and over, Animals, Antineoplastic Agents/adverse effects, Antineoplastic Agents/therapeutic use, Carbazoles/adverse effects, Carbazoles/therapeutic use, Carcinoma, Non-Small-Cell Lung/drug therapy, Non-Small-Cell Lung/mortality, Central Nervous System Neoplasms/drug therapy, Central Nervous System Neoplasms/secondary, Disease-Free Survival, Female, Follow-Up Studies, Humans, Intention to Treat Analysis, Kaplan-Meier Estimate, Lung Neoplasms/drug therapy, Lung Neoplasms/mortality, Male, Middle Aged, Piperidines/adverse effects, Piperidines/therapeutic use, Protein Kinase Inhibitors/adverse effects, Protein Kinase Inhibitors/therapeutic use, Pyrazoles/adverse effects, Pyrazoles/therapeutic use, Pyridines/adverse effects
Popis súboru: application/pdf
Relation: New England Journal of Medicine; https://iris.unil.ch/handle/iris/196537; serval:BIB_A7C6AEF21441; 000408626400006
-
20
Autori: a ďalší
Prispievatelia: a ďalší
Predmety: Adult, Anti-HIV Agents/adverse effects, Anti-Retroviral Agents/adverse effects, Antiretroviral Therapy, Highly Active/adverse effects, Female, HIV Infections/complications, HIV Infections/drug therapy, HIV Protease Inhibitors/adverse effects, Humans, Male, Metabolic Syndrome X/chemically induced, Models, Statistical, Oligopeptides/adverse effects, Prospective Studies, Pyridines/adverse effects, Reverse Transcriptase Inhibitors/adverse effects, Risk Factors, Stavudine/adverse effects, Switzerland
Relation: Journal of Clinical Epidemiology; https://iris.unil.ch/handle/iris/180918; serval:BIB_DADAFC5F4F9A; 000266291600013
Nájsť tento článok vo Web of Science 
Full Text 
Full Text Finder